Alnylam Pharmaceuticals
ALNY
#644
Rank
C$45.42 B
Marketcap
$346.67
Share price
-1.32%
Change (1 day)
70.49%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company